{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:59:45Z","timestamp":1793977185869,"version":"4.8.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2024368421"],"award-info":[{"award-number":["2024368421"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2024361899"],"award-info":[{"award-number":["2024361899"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5 T32 DK 120520-5"],"award-info":[{"award-number":["5 T32 DK 120520-5"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Biophysics and Molecular Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pbiomolbio.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:17:35Z","timestamp":1781461055000},"page":"189-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Uncovering the biological mechanisms of TREM2 with molecular simulations: A comprehensive review and perspective"],"prefix":"10.1016","volume":"201","author":[{"given":"Emma E.","family":"Lietzke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Aldrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Ferreira","family":"de Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley D.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7505-7920","authenticated-orcid":false,"given":"Kayla G.","family":"Sprenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092648","article-title":"Evidence of Trem2 variant associated with triple risk of alzheimer's disease","volume":"9","author":"Abduljaleel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2023.184230","article-title":"Molecular dynamics simulation of apolipoprotein E3 lipid nanodiscs","volume":"1866","author":"Allen","year":"2024","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib5","article-title":"Unlocking therapeutic potential: computational insights into TREM2 protein targeting with FDA-Approved drugs for neurodegeneration","author":"Alrouji","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib6","doi-asserted-by":"crossref","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","article-title":"Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"290","author":"Atagi","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib7","doi-asserted-by":"crossref","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","article-title":"The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E","volume":"290","author":"Bailey","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib8","doi-asserted-by":"crossref","first-page":"13590","DOI":"10.1021\/jp507027t","article-title":"Dynamics of lipids, cholesterol, and transmembrane \u03b1-Helices from microsecond molecular dynamics simulations","volume":"118","author":"Baker","year":"2014","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114486119","article-title":"Soluble TREM2 inhibits secondary nucleation of A\u03b2 fibrillization and enhances cellular uptake of fibrillar A\u03b2","volume":"119","author":"Belsare","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2013.09.017","article-title":"Heterozygous TREM2 mutations in frontotemporal dementia","volume":"35","author":"Borroni","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib11","series-title":"Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing 84\u2013es","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00401-019-02013-z","article-title":"Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease","volume":"138","author":"Boza-Serrano","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2020.105796","article-title":"Development of a robust crystallization platform for immune receptor TREM2 using a crystallization chaperone strategy","volume":"179","author":"Byrne","year":"2021","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2353\/ajpath.2007.070182","article-title":"TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions","volume":"171","author":"Cairns","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ni.1943","article-title":"The structural basis for intramembrane assembly of an activating immunoreceptor complex","volume":"11","author":"Call","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ni.1943","article-title":"The structural basis for intramembrane assembly of an activating immunoreceptor complex","volume":"11","author":"Call","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00251-011-0562-4","article-title":"Specific lipid recognition is a general feature of CD300 and TREM molecules","volume":"64","author":"Cannon","year":"2012","journal-title":"Immunogenetics"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib18","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/nn.4126","article-title":"CD33 modulates TREM2: convergence of alzheimer loci","volume":"18","author":"Chan","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib19","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1038\/s41467-018-05255-9","article-title":"How nanoscale protein interactions determine the mesoscale dynamic organisation of bacterial outer membrane proteins","volume":"9","author":"Chavent","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib20","doi-asserted-by":"crossref","first-page":"12620","DOI":"10.1074\/jbc.RA118.001848","article-title":"TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2R47H on murine myeloid cell function","volume":"293","author":"Cheng","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-018-0262-8","article-title":"The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease","volume":"13","author":"Cheng-Hathaway","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500718","article-title":"Structure\u2010based virtual screening identifies TREM2\u2010Targeted small molecules that enhance microglial phagocytosis","volume":"21","author":"Cho","year":"2026","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s10020-025-01229-y","article-title":"Drug screening targeting TREM2-TYROBP transmembrane binding","volume":"31","author":"Cobas-Carre\u00f1o","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib24","series-title":"Osteoimmunology","first-page":"97","article-title":"The enigmatic function of TREM-2 in osteoclastogenesis","author":"Colonna","year":"2007"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1053\/j.gastro.2012.10.040","article-title":"Bacterial sensor triggering receptor expressed on myeloid Cells-2 regulates the mucosal inflammatory response","volume":"144","author":"Correale","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91207-1","article-title":"Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome","volume":"11","author":"Cosker","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12974-023-02945-0","article-title":"Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal\/multi-tracer PET\/MRI imaging study with influenza vaccine immune challenge","volume":"20","author":"Cousins","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib28","doi-asserted-by":"crossref","first-page":"726.e11","DOI":"10.1016\/j.neurobiolaging.2013.09.009","article-title":"Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia","volume":"35","author":"Cuyvers","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2546554","article-title":"Building a potent TREM2 agonistic, biparatopic, common light chain antibody","volume":"17","author":"da Silva Almeida","year":"2025","journal-title":"mAbs"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2024.105449","article-title":"Exploring the orphan immune receptor TREM2 and its non-protein ligands: in silico characterization","volume":"266","author":"Dantas","year":"2025","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2025.109058","article-title":"Protein recognition is chiefly mediated by the CDR2 region in TREM2 - an in silico characterization","volume":"138","author":"Dantas","year":"2025","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib32","doi-asserted-by":"crossref","first-page":"194.e13","DOI":"10.1016\/j.neurobiolaging.2017.01.015","article-title":"A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature","volume":"53","author":"Dardiotis","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-13120-5","article-title":"Dynamic insights into the effects of nonsynonymous polymorphisms (nsSNPs) on loss of TREM2 function","volume":"12","author":"Dash","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60561-x","article-title":"Mechanistic insights into the deleterious roles of Nasu-Hakola disease associated TREM2 variants","volume":"10","author":"Dash","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.171.2.594","article-title":"Pattern recognition by TREM-2: binding of anionic ligands","volume":"171","author":"Daws","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib36","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer's disease and risk stratification by polygenic risk scores","volume":"12","author":"de Rojas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14124","article-title":"Multimerization of TREM2 is impaired by Alzheimer's disease\u2013associated variants","author":"Dean","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2026.e00867","article-title":"Cholecalciferol (vitamin D3) is an agonist of the Alzheimer's disease-associated immune receptor TREM2","volume":"23","author":"Dean","year":"2026","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01252","article-title":"Neurodegenerative disease\u2013associated variants in TREM2 destabilize the apical ligand-binding Region of the immunoglobulin domain","volume":"10","author":"Dean","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-019-0319-3","article-title":"TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers","volume":"14","author":"Del-Aguila","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib41","doi-asserted-by":"crossref","first-page":"E5281","DOI":"10.1073\/pnas.1606482113","article-title":"Impact of membrane lipid composition on the structure and stability of the transmembrane domain of amyloid precursor protein","volume":"113","author":"Dominguez","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib42","doi-asserted-by":"crossref","first-page":"19053","DOI":"10.1074\/jbc.271.32.19053","article-title":"Human apolipoprotein E4 domain Interaction: arginine 61 AND glutamic acid 255 interact to direct the preference for very low density lipoproteins","volume":"271","author":"Dong","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib43","article-title":"A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease","volume":"12","author":"Edwin","year":"2020","journal-title":"Alzheimer's Dement.: Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav6221","article-title":"Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease","volume":"11","author":"Ewers","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2017.09.034","article-title":"ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157","volume":"660","author":"Feuerbach","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-020-00407-2","article-title":"Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration","volume":"15","author":"Franzmeier","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib47","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1705080114","article-title":"A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain\u2013domain interactions","volume":"114","author":"Frieden","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib50","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1021\/bi1020106","article-title":"Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles","volume":"50","author":"Garai","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib49","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1021\/bi101407m","article-title":"The association\u2212dissociation behavior of the ApoE proteins: kinetic and equilibrium studies","volume":"49","author":"Garai","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib51","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3233\/JAD-231150","article-title":"An insertion within SIRP\u03b21 shows a dual effect over alzheimer's disease cognitive decline altering the microglial response","volume":"98","author":"Garc\u00eda-Alberca","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib52","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.celrep.2018.07.094","article-title":"Human induced pluripotent stem cell-derived microglia-like cells harboring TREM2 missense mutations show specific deficits in phagocytosis","volume":"24","author":"Garcia-Reitboeck","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70729","article-title":"TREM2-apoE3 interactions and Alzheimer's disease: molecular and structural insights and effects of TREM2 R47H and apoE4 variants","volume":"21","author":"Greer","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-024-00795-9","article-title":"Biophysical mapping of TREM2-ligand interactions reveals shared surfaces for engagement of multiple Alzheimer's disease ligands","volume":"20","author":"Greven","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in alzheimer's disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib56","doi-asserted-by":"crossref","first-page":"2890.e1","DOI":"10.1016\/j.neurobiolaging.2013.06.005","article-title":"A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family","volume":"34","author":"Guerreiro","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","article-title":"Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia\u2013like syndrome without bone involvement","volume":"70","author":"Guerreiro","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib58","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.177.4.2051","article-title":"Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP121","volume":"177","author":"Hamerman","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-065X.2009.00841.x","article-title":"The expanding roles of ITAM adapters FcR\u03b3 and DAP12 in myeloid cells","volume":"232","author":"Hamerman","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib60","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamaneurol.2013.396","article-title":"Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical TrialApolipoprotein E lipidation and amyloid peptides","volume":"70","author":"Hanson","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib61","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib62","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jnen\/nlw067","article-title":"Apolipoprotein E genotype affects size of ApoE complexes in cerebrospinal fluid","volume":"75","author":"Heinsinger","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib63","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2405474121","article-title":"Single-cell analysis identifies distinct macrophage phenotypes associated with prodisease and proresolving functions in the endometriotic niche","volume":"121","author":"Henlon","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006165","article-title":"Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach","volume":"14","author":"Henry","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib65","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/s41467-024-52442-y","article-title":"Rapid affinity optimization of an anti-TREM2 clinical lead antibody by cross-lineage immune repertoire mining","volume":"15","author":"Hsiao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib66","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","article-title":"A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia","volume":"109","author":"Hsieh","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib68","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/glia.23953","article-title":"A reporter cell system for the triggering receptor expressed on myeloid cells 2 reveals differential effects of disease-associated variants on receptor signaling and activation by antibodies against the stalk region","volume":"69","author":"Ibach","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib69","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1021\/acs.jpcb.0c03368","article-title":"Capturing biologically complex tissue-specific membranes at different levels of compositional complexity","volume":"124","author":"Ing\u00f3lfsson","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib70","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1158\/1538-7445.AM2025-3136","article-title":"Abstract 3136: EOS-215, a first-in-class TREM2 antagonist, designed to reprogram the tumor microenvironment and overcome resistance","volume":"85","author":"Janss","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib71","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002325RR","article-title":"Cyclophilin A is an endogenous ligand for the triggering receptor expressed on myeloid cells-2 (TREM2)","volume":"35","author":"Ji","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib72","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","article-title":"Coding variants in TREM2 increase risk for Alzheimer's disease","volume":"23","author":"Jin","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of alzheimer's disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib74","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib75","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1523\/JNEUROSCI.2620-14.2015","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke","volume":"35","author":"Kawabori","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib76","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of alzheimer's disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib77","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/JLB.2HI0720-463RR","article-title":"Novel TREM2 splicing isoform that lacks the V-set immunoglobulin domain is abundant in the human brain","volume":"110","author":"Kiianitsa","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib79","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.15252\/embj.201796516","article-title":"The FTD\u2010like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism","volume":"36","author":"Kleinberger","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib80","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1212\/01.WNL.0000160304.00003.CA","article-title":"The genetic causes of basal ganglia calcification, dementia, and bone cysts","volume":"64","author":"Kl\u00fcnemann","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib82","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20391","article-title":"Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms","volume":"5","author":"Kober","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib83","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/alz.12194","article-title":"Functional insights from biophysical study of TREM2 interactions with apoE and A\u03b21-42","volume":"17","author":"Kober","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib81","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jmb.2017.04.004","article-title":"TREM2-Ligand interactions in health and disease","volume":"429","author":"Kober","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.735524","article-title":"Uncovering disease mechanisms in a novel mouse model expressing humanized APOE\u03b54 and Trem2\u2217R47H","volume":"13","author":"Kotredes","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib85","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib86","doi-asserted-by":"crossref","first-page":"2419.e23","DOI":"10.1016\/j.neurobiolaging.2014.04.010","article-title":"Homozygous TREM2 mutation in a family with atypical frontotemporal dementia","volume":"35","author":"Le Ber","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib87","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1021\/jacs.6b05602","article-title":"Conformational changes in the epidermal growth factor receptor: role of the transmembrane domain investigated by coarse-grained MetaDynamics free energy calculations","volume":"138","author":"Lelimousin","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib88","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809027","article-title":"High\u2010affinity interactions and signal transduction between A\u03b2 oligomers and TREM2","volume":"10","author":"Lessard","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib89","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809027","article-title":"High\u2010affinity interactions and signal transduction between A\u03b2 oligomers and TREM2","volume":"10","author":"Lessard","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103057","article-title":"A natural small molecule aspidosperma-type alkaloid, hecubine, as a new TREM2 activator for alleviating lipopolysaccharide-induced neuroinflammation in vitro and in vivo","volume":"70","author":"Li","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib90","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00413-4","article-title":"APOE2: protective mechanism and therapeutic implications for Alzheimer's disease","volume":"15","author":"Li","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70120","article-title":"Synergistic reduction in interfacial flexibility of TREM2R47H and ApoE4 may underlie AD pathology","volume":"21","author":"Lietzke","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib93","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.14283\/jpad.2024.164","article-title":"Roles of TREM2 in the pathological mechanism and the therapeutic strategies of alzheimer's disease","volume":"11","author":"Lin","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib96","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","author":"Mahley","year":"2019"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib94","first-page":"622","article-title":"Cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science (1979)"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib95","doi-asserted-by":"crossref","DOI":"10.1097\/00041433-199906000-00003","article-title":"Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond","volume":"10","author":"Mahley","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib97","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1515\/tnsci-2022-0218","article-title":"Molecular recognition of the interaction between ApoE and the TREM2 protein","volume":"13","author":"Mai","year":"2022","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib98","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107691","article-title":"TREM2 on microglia cell surface binds to and forms functional binary complexes with heparan sulfate modified with 6-O-sulfation and iduronic acid","volume":"300","author":"McMillan","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib100","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1038\/s41467-024-52301-w","article-title":"Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an Alzheimer's disease mouse model","volume":"15","author":"Milazzo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib101","article-title":"Characterization of the first TREM2 small molecule agonist, VG-3927, for clinical development in Alzheimer's disease","volume":"20","author":"Mirescu","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.126281","article-title":"Insights into lipid-modified recognition of apolipoprotein E3 to extra-cellular domain of TREM2 associated with Alzheimer's disease","volume":"415","author":"Mishra","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e41414","article-title":"Extracellular domain of TREM2 possess two distinct ligand recognition sites: insights from machine-learning guided docking and all-atoms molecular dynamics simulations","volume":"11","author":"Mishra","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib104","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 modulation remodels the tumor myeloid landscape enhancing Anti-PD-1 immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib105","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1038\/s41598-019-40438-4","article-title":"ApoE-fragment\/A\u03b2 heteromers in the brain of patients with Alzheimer's disease","volume":"9","author":"Mouchard","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13073-023-01160-z","article-title":"TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation","volume":"15","author":"Moutinho","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1083\/jcb.200808080","article-title":"TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria","volume":"184","author":"N'Diaye","year":"2009","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib107","first-page":"130","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science (1979)"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib108","doi-asserted-by":"crossref","first-page":"160.e15","DOI":"10.1016\/j.neurobiolaging.2018.04.003","article-title":"Targeted exome sequencing reveals homozygous TREM2 R47C mutation presenting with behavioral variant frontotemporal dementia without bone involvement","volume":"68","author":"Ng","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib109","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-biophys-083012-130257","article-title":"The underappreciated role of allostery in the cellular network","volume":"42","author":"Nussinov","year":"2013","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib111","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96144-7","article-title":"PLC\u03b32 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages","volume":"11","author":"Obst","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib112","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/jvi.69.6.3584-3596.1995","article-title":"Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs","volume":"69","author":"Ou","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00618","article-title":"The Alzheimer's disease-associated R47H variant of TREM2 has an altered glycosylation pattern and protein stability","volume":"10","author":"Park","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib114","article-title":"The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease","volume":"11","author":"Park","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib115","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s44161-023-00354-3","article-title":"Trem2 promotes foamy macrophage lipid uptake and survival in atherosclerosis","volume":"2","author":"Patterson","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib116","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/odi.14004","article-title":"Triggering receptor expressed on myeloid cells-2 stimulates osteoclast differentiation and bone loss in periodontitis","volume":"28","author":"Pei","year":"2022","journal-title":"Oral Dis."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000500","article-title":"TREM2- and DAP12-Dependent activation of PI3K requires DAP10 and is inhibited by SHIP1","volume":"3","author":"Peng","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib119","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1194\/jlr.M600545-JLR200","article-title":"Apolipoprotein e\u2022dipalmitoylphosphatidylcholine particles are ellipsoidal in solutions","volume":"48","author":"Peters-Libeu","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib118","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1074\/jbc.M510851200","article-title":"Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine","volume":"281","author":"Peters-Libeu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.molimm.2014.07.023","article-title":"3-O-sulfo-\u03b2-d-galactose moiety of endogenous sulfoglycolipids is a potential ligand for immunoglobulin-like receptor LMIR5","volume":"63","author":"Phongsisay","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib122","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.molimm.2014.07.023","article-title":"3-O-sulfo-\u03b2-d-galactose moiety of endogenous sulfoglycolipids is a potential ligand for immunoglobulin-like receptor LMIR5","volume":"63","author":"Phongsisay","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib121","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.molimm.2015.05.008","article-title":"Evidence for TLR4 and FcR\u03b3\u2013CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors","volume":"66","author":"Phongsisay","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib123","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1096\/fj.201902447R","article-title":"A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia","volume":"34","author":"Piers","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib124","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1172\/JCI77983","article-title":"TREM2 sustains microglial expansion during aging and response to demyelination","volume":"125","author":"Poliani","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib125","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1021\/acs.jpcb.1c03011","article-title":"Conformational Reorganization of Apolipoprotein e Triggered by Phospholipid Assembly","volume":"125","author":"Prakashchand","year":"2021","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib128","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-019-02048-2","article-title":"Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer's disease patient brain samples","volume":"138","author":"Prokop","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib126","doi-asserted-by":"crossref","DOI":"10.1093\/protein\/12.6.475","article-title":"Structural characterization by computer experiments of the lipid-free LDL-Receptor-Binding domain of apolipoprotein E","volume":"12","author":"Pr\u00e9vost","year":"1999","journal-title":"Protein Eng."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib127","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1021\/jp003347x","article-title":"Interactions of the N-terminal domain of apolipoprotein E with a mimetic water-lipid surface: a molecular dynamics study","volume":"105","author":"Pr\u00e9vost","year":"2001","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.pbiomolbio.2026.06.002_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib130","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib131","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jalz.2014.10.013","article-title":"The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia","volume":"11","author":"Roussos","year":"2015","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib132","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.102269","article-title":"The flexible stalk domain of sTREM2 modulates its interactions with brain-based phospholipids","volume":"13","author":"Saeb","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib133","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911227","article-title":"Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region","volume":"12","author":"Schlepckow","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib134","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3233\/JAD-215602","article-title":"An alternatively spliced TREM2 isoform lacking the ligand binding domain is expressed in human brain","volume":"87","author":"Shaw","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jb\/mvac073","article-title":"The role of TREM2 N-glycans in trafficking to the cell surface and signal transduction of TREM2","volume":"172","author":"Shirotani","year":"2022","journal-title":"J. Biochem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib136","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ng.3916","article-title":"Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease","volume":"49","author":"Sims","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib137","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40478-016-0367-7","article-title":"Rare TREM2 variants associated with Alzheimer's disease display reduced cell surface expression","volume":"4","author":"Sirkis","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib138","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1091\/mbc.e17-06-0423","article-title":"Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER\u2013Golgi intermediate compartment","volume":"28","author":"Sirkis","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib139","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1491","article-title":"Novel variants in POLH and TREM2 genes associated with a complex phenotype of Xeroderma pigmentosum variant type and early\u2010onset dementia","volume":"8","author":"Soares","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","article-title":"Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation","volume":"13","author":"Song","year":"2017","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib141","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.20171529","article-title":"Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism","volume":"215","author":"Song","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100872","article-title":"Lipid and lipoprotein metabolism in microglia: alzheimer's disease mechanisms and interventions","volume":"66","author":"Sprenger","year":"2025","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib143","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1471-4159.2009.06130.x","article-title":"The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor","volume":"110","author":"Stefano","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib144","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104247","article-title":"\u03b3\u2010Secretase cleavage of the alzheimer risk factor TREM2 is determined by its intrinsic structural dynamics","volume":"39","author":"Steiner","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib145","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.neuron.2023.12.018","article-title":"Apolipoprotein E secreted by astrocytes forms antiparallel dimers in discoidal lipoproteins","volume":"112","author":"Strickland","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib146","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215371120","article-title":"Apolipoprotein E4 has extensive conformational heterogeneity in lipid-free and lipid-bound forms","volume":"120","author":"Stuchell-Brereton","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib149","doi-asserted-by":"crossref","first-page":"12634","DOI":"10.1074\/jbc.RA118.002352","article-title":"Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2","volume":"293","author":"Sudom","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib148","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early\u2010stage Alzheimer's disease and associate with neuronal injury markers","volume":"8","author":"Su\u00e1rez\u2010Calvet","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","article-title":"Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology","volume":"14","author":"Su\u00e1rez-Calvet","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib150","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.str.2021.06.010","article-title":"Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain","volume":"29","author":"Szykowska","year":"2021","journal-title":"Structure"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib151","doi-asserted-by":"crossref","first-page":"2657.e13","DOI":"10.1016\/j.neurobiolaging.2014.06.018","article-title":"Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes","volume":"35","author":"Thelen","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib152","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1194\/jlr.R800010-JLR200","article-title":"Three-dimensional models of HDL apoA-I: implications for its assembly and function","volume":"49","author":"Thomas","year":"2008","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpc.2021.108171","article-title":"LAMMPS - a flexible simulation tool for particle-based materials modeling at the atomic, meso, and continuum scales","volume":"271","author":"Thompson","year":"2022","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib154","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.15252\/emmm.201707673","article-title":"TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant","volume":"9","author":"Thornton","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib156","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 maintains microglial metabolic fitness in alzheimer's disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 \u2014 a key player in microglial biology and alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib157","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","article-title":"ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE","volume":"279","author":"Wahrle","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139394","article-title":"Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study","volume":"294","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib158","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib160","doi-asserted-by":"crossref","first-page":"5.6.1","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib161","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1021\/acs.jctc.1c00276","article-title":"Impact of increased membrane realism on conformational sampling of proteins","volume":"17","author":"Weigle","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib162","first-page":"249","article-title":"Structure-function relationships","volume":"vol. 45","author":"Weisgraber","year":"1994"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib163","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41467-024-49028-z","article-title":"Co-aggregation with apolipoprotein E modulates the function of Amyloid-\u03b2 in Alzheimer's disease","volume":"15","author":"Xia","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib164","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41593-021-00975-6","article-title":"TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration","volume":"25","author":"Xie","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib165","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbi.2019.07.004","article-title":"Efficacy and mechanism of cGAMP to suppress Alzheimer's disease by elevating TREM2","volume":"81","author":"Xu","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib166","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12964-024-01642-6","article-title":"Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2\/STAT3 and NF-\u03baB pathways","volume":"22","author":"Yan","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib167","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","article-title":"Apolipoprotein E in lipid metabolism and neurodegenerative disease","volume":"34","author":"Yang","year":"2023","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib168","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00457","article-title":"Distinct signaling pathways regulate TREM2 phagocytic and NF\u03baB antagonistic activities","volume":"13","author":"Yao","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib169","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib170","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010959","article-title":"Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer","volume":"13","author":"Yeku","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib171","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.stem.2023.07.006","article-title":"A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer's disease","volume":"30","author":"Yoo","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib172","doi-asserted-by":"crossref","first-page":"10722","DOI":"10.1021\/bi700672v","article-title":"A monomeric, biologically active, full-length human apolipoprotein E","volume":"46","author":"Zhang","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib173","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 is a receptor for \u03b2-Amyloid that mediates microglial function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib174","doi-asserted-by":"crossref","first-page":"15866","DOI":"10.1074\/jbc.M115.645986","article-title":"DAP12 stabilizes the C-terminal fragment of the triggering receptor expressed on myeloid Cells-2 (TREM2) and protects against LPS-induced pro-inflammatory response","volume":"290","author":"Zhong","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-018-0247-7","article-title":"Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"13","author":"Zhong","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib176","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.immuni.2023.06.016","article-title":"TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration","volume":"56","author":"Zhong","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib178","doi-asserted-by":"crossref","first-page":"13315","DOI":"10.1021\/acs.jcim.5c01891","article-title":"Mechanistic disruption of the TREM2\u2013DAP12 transmembrane complex by alzheimer's disease mutations: a multiscale simulation study","volume":"65","author":"Zhong","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.pbiomolbio.2026.06.002_bib177","doi-asserted-by":"crossref","first-page":"28715","DOI":"10.1021\/acsomega.4c03060","article-title":"Unraveling the molecular dance: insights into TREM2\/DAP12 complex formation in alzheimer's disease through molecular dynamics simulations","volume":"9","author":"Zhong","year":"2024","journal-title":"ACS Omega"}],"container-title":["Progress in Biophysics and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610726000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610726000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:40:18Z","timestamp":1787431218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079610726000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":177,"alternative-id":["S0079610726000416"],"URL":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2026.06.002","relation":{},"ISSN":["0079-6107"],"issn-type":[{"value":"0079-6107","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering the biological mechanisms of TREM2 with molecular simulations: A comprehensive review and perspective","name":"articletitle","label":"Article Title"},{"value":"Progress in Biophysics and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}